Connection

Elizabeth Garrett-Mayer to Administration, Oral

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Administration, Oral.
Elizabeth Garrett-Mayer
Connection Strength
0.018
Administration, Oral
  1. Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide. Blood. 2009 May 14; 113(20):4841-52.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.